Friebe Kristin, Klapdor Rüdiger, Hillemanns Peter, Jentschke Matthias
Klinik für Frauenheilkunde und Geburtshilfe, Medizinische Hochschule Hannover, Hannover, Germany.
Geburtshilfe Frauenheilkd. 2017 Aug;77(8):887-893. doi: 10.1055/s-0043-115395. Epub 2017 Aug 24.
In this retrospective study partial genotyping of human papilloma viruses (HPV) using the Abbott RealTime HighRisk HPV Test (RealTime) was compared with simple HPV detection (Qiagen Hybrid Capture 2 Test; hc2) for recurrence prediction at the first follow-up examination after conization of cervical intraepithelial neoplasia (CIN).
144 women who had undergone conization for CIN between January 2007 and December 2013 were included. HPV status was determined preoperatively and at first follow-up using hc2 in 103 women and RealTime in 41 women. Recurrent or persistent CIN was assumed when CIN2+ was confirmed histologically or on comparable cytology findings.
Of the 144 women with complete data 12 (8.3%) had a recurrence after conization. HPV persistence at follow-up correlated significantly with recurrence (hc2: p = 0.003; RealTime: p = 0.003) and both sensitivity and specificity were high (hc2 = 100 and 78.4% respectively; RealTime = 75.0 and 83.9%). Whereas isolated HPV testing had a relatively low positive predictive value for recurrence (hc2 16%; RealTime 54.5%), this rose to 80% with HPV 16 detection at follow-up.
At follow-up after conization of CIN the combination of high risk HPV detection and partial genotyping of HPV 16 constitutes excellent diagnostic criteria for recurrence/persistence of CIN.
在这项回顾性研究中,将使用雅培实时高危人乳头瘤病毒检测(实时检测)对人乳头瘤病毒(HPV)进行的部分基因分型与单纯HPV检测(凯杰杂交捕获2检测;hc2)相比较,以预测宫颈上皮内瘤变(CIN)锥切术后首次随访检查时的复发情况。
纳入了2007年1月至2013年12月期间因CIN接受锥切术的144名女性。103名女性术前及首次随访时使用hc2检测HPV状态,41名女性使用实时检测。当组织学确诊为CIN2+或有类似细胞学检查结果时,假定为复发性或持续性CIN。
在144名有完整数据的女性中,12名(8.3%)锥切术后复发。随访时HPV持续存在与复发显著相关(hc2:p = 0.003;实时检测:p = 0.003),敏感性和特异性均较高(hc2分别为100%和78.4%;实时检测为75.0%和83.9%)。单独的HPV检测对复发的阳性预测值相对较低(hc2为16%;实时检测为54.5%),随访时检测到HPV 16则该值升至80%。
在CIN锥切术后的随访中,高危HPV检测与HPV 16部分基因分型相结合构成了CIN复发/持续的优秀诊断标准。